Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ80H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,056
Award facts
- Contract value 100% obligated
- $21,055.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,055.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on November 24, 2025, with completion scheduled for November 25, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and federal agencies. Dupixent is a specialty biologic medication used to treat inflammatory conditions including atopic dermatitis, asthma, and eosinophilic esophagitis. This delivery order represents one of numerous competitive contract awards the company has received through DLA's medical supply chain, demonstrating its capability to fulfill federal healthcare procurement requirements across multiple therapeutic domains. The SPE2DX vehicle under which this order was issued represents a flexible global pharmaceutical support mechanism serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FZ80H?
SPE2DR26FZ80H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FZ80H worth?
The government has obligated $21,056 on SPE2DR26FZ80H.
Is contract SPE2DR26FZ80H an order under another contract?
Yes. SPE2DR26FZ80H is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ80H competed?
The extent of competition for SPE2DR26FZ80H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award